Evaluation of positive care effects and health economic significance of a patient-centered gait analysis app for use in the home with telehealth monitoring.
Not Applicable
- Conditions
- G20.10
- Registration Number
- DRKS00030699
- Lead Sponsor
- Abteilung für Molekulare Neurologie, Universitätsklinik Erlangen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 68
Inclusion Criteria
1. idiopathic parkinsonian syndrome (H&Y II-III).
2. UPDRS III > 13 with involvement uEx
3. ability to walk > 10 m without support
4. minimal mental status test (MMST) score = 26.
5. willingness of the study participant to take up therapy measures (e.g., drug therapy, exercise therapy) (already prior to study participation).
Exclusion Criteria
1. tremor dominant parkinsonian syndrome
2. risk of falling with high injury potential
3. if included, current or planned inpatient stay within the next two weeks
4. severe ON freezing
5. severe internistic/orthopedic/psychological comorbidities
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Close-In-, Intermis-, Close-Out-Analysis: MDS-UPDRS III
- Secondary Outcome Measures
Name Time Method Healthstate: MDS-UPDRS (II, IIII, IV), Lindop-PAS, Mini-Best-Test,10m-Walk-Test, ABC-Scale, PASE, ErFOF-Q, CGI-C, Quality of Life: EQ-5D-5L, PDQ39, Health-Literacy in Parkinson's Disease (ErPDKT, ErAIC-PD, self-designed), Patient Souvereignity (SSE, PAM-13D, Decision-Self-Efficacy Scale)